Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Statistics

Total Valuation

KOSDAQ:950160 has a market cap or net worth of KRW 3.74 trillion. The enterprise value is 3.75 trillion.

Market Cap	3.74T
Enterprise Value	3.75T

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:950160 has 83.01 million shares outstanding. The number of shares has increased by 7.73% in one year.

Current Share Class	n/a
Shares Outstanding	83.01M
Shares Change (YoY)	+7.73%
Shares Change (QoQ)	+1.05%
Owned by Insiders (%)	18.36%
Owned by Institutions (%)	0.00%
Float	16.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	680.10
PB Ratio	32.22
P/TBV Ratio	32.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-42.76
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-155.13

Financial Position

The company has a current ratio of 0.21, with a Debt / Equity ratio of 0.39.

Current Ratio	0.21
Quick Ratio	0.17
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	-1.86
Interest Coverage	-284.68

Financial Efficiency

Return on equity (ROE) is -63.01% and return on invested capital (ROIC) is -8.77%.

Return on Equity (ROE)	-63.01%
Return on Assets (ROA)	-6.27%
Return on Invested Capital (ROIC)	-8.77%
Return on Capital Employed (ROCE)	-19.22%
Revenue Per Employee	189.40M
Profits Per Employee	-3.03B
Employee Count	29
Asset Turnover	0.02
Inventory Turnover	51.76

Taxes

In the past 12 months, KOSDAQ:950160 has paid 55.54 million in taxes.

Income Tax	55.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +221.66% in the last 52 weeks. The beta is -0.66, so KOSDAQ:950160's price volatility has been lower than the market average.

Beta (5Y)	-0.66
52-Week Price Change	+221.66%
50-Day Moving Average	41,767.00
200-Day Moving Average	39,207.00
Relative Strength Index (RSI)	49.69
Average Volume (20 Days)	578,379

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:950160 had revenue of KRW 5.49 billion and -87.80 billion in losses. Loss per share was -1,097.18.

Revenue	5.49B
Gross Profit	625.47M
Operating Income	-23.17B
Pretax Income	-87.75B
Net Income	-87.80B
EBITDA	-22.43B
EBIT	-23.17B
Loss Per Share	-1,097.18

Balance Sheet

The company has 26.60 billion in cash and 45.12 billion in debt, giving a net cash position of -18.52 billion or -223.14 per share.

Cash & Cash Equivalents	26.60B
Total Debt	45.12B
Net Cash	-18.52B
Net Cash Per Share	-223.14
Equity (Book Value)	115.95B
Book Value Per Share	1,419.44
Working Capital	-125.02B

Cash Flow

In the last 12 months, operating cash flow was -23.48 billion and capital expenditures -722.97 million, giving a free cash flow of -24.20 billion.

Operating Cash Flow	-23.48B
Capital Expenditures	-722.97M
Free Cash Flow	-24.20B
FCF Per Share	-291.51

Margins

Gross Margin	11.39%
Operating Margin	-421.77%
Pretax Margin	-1,597.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:950160 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.73%
Shareholder Yield	n/a
Earnings Yield	-2.35%
FCF Yield	-0.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:950160 has an Altman Z-Score of 5.13 and a Piotroski F-Score of 2.

Altman Z-Score	5.13
Piotroski F-Score	2